Clinical trial
Comparing Intensive and Standard Training for Human Insulin Inhalation Powder…
NCT00099515 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00099515 |
|---|---|
| Title | Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP) |
| Official title | Standard Training Versus Intensive Training for HIIP Delivery System Usage in Insulin-Naïve Patients With Type 2 Diabetes Mellitus |
| Acronym | IDAP |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | Alkermes, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | LY041001 (HIIP) |
| Enrollment | 97 |
| Start date | Nov 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | Dec 16, 2004 |
| Last update posted | Dec 21, 2007 |
| Countries | Argentina, Portugal, South Africa, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: